Clinical Observation of Gemcitabine Combined with Cisplatin in the Treatment of Triple Negative Metastatic Breast Cancer Resistance to Taxane and Anthracycline

YU Jingping

doi:10.14033/j.cnki.cfmr.2018.36.002

Home>Articles>Clinical Observation of Gemcitabine Combined with Cisplatin in the Treatment of Triple Negative Metastatic Breast Cancer Resistance to Taxane and Anthracycline

DOI: 10.14033/j.cnki.cfmr.2018.36.002

Clinical Observation of Gemcitabine Combined with Cisplatin in the Treatment of Triple Negative Metastatic Breast Cancer Resistance to Taxane and Anthracycline

YU Jingping

Machine-generated Keywords：

Publication Date：2018-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 4-7 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2018,16(36)